Latest Publication

Glycolipids_Market.JPG

Glycolipids Market Size, Share & Trends Analysis Report By Type (Glycosyl Triacylglycerol, Glycosphingolipid, and Others), By Application (Food, Nutrition & Supplements, Pharmaceuticals, and Others), By Region, And By Segment Forecasts, 2024-2031.

Glycolipids Market Size is valued at USD 3.02 Bn in 2023 and is predicted to reach USD 4.37 Bn by the year 2031 at a 4.8% CAGR during the forecast period for 2024-2031. Glycolipids consist of a carbohydrate (sugar) that is bonded to a lipid (fat) ...

View Sample PDF

Chlorphenamine_Maleate_API_Market.JPG

Chlorphenamine Maleate API Market Size, Share & Trends Analysis Report By Type (Purity?No Higher Than 98%, Purity?Higher Than 98%) by Application (Tablets, Injection), By Region, And By Segment Forecasts, 2024-2031.

Chlorphenamine Maleate API Market Size is valued at USD 70.2 Mn in 2023 and is predicted to reach USD 120.5 Mn by the year 2031 at a 7.20% CAGR during the forecast period for 2024-2031. Chlorphenamine maleate is an important active pharm...

View Sample PDF

Recycled_Elastomers_Market.JPG

Recycled Elastomers Market Size, Share & Trends Analysis Report By Material Type (Synthetic and Natural), Synthetic Type (Thermoset and Thermoplastic), Thermoset (Recycled Rubber, Recycled Polyurethane, and Other Thermosets), Thermoplastic (Styrenic Block Copolymers (SBC), Thermoplastic Polyurethane (TPU), Thermoplastic Vulcanizate (TPV), and Other Thermoplastics), Application, By Region, And By Segment Forecasts, 2024-2031.

Recycled Elastomers Market Size is valued at USD 9.5 Bn in 2023 and is predicted to reach USD 20.2 Bn by the year 2031 at a 10.1% CAGR during the forecast period for 2024-2031. Recycled elastomers refer to rubber materials that have undergone recl...

View Sample PDF

Gene_Therapy_on_Cardiovascular_Disease_Market.JPG

Gene Therapy on Cardiovascular Disease Market Size, Share & Trends Analysis Report By Type (Viral Gene Therapy, Non-Viral Gene Therapy), By Application (Heart Disease, Vascular Disease), By Region, And By Segment Forecasts, 2024-2031.

Gene Therapy on Cardiovascular Disease Market Size is predicted to grow at a 67.4% CAGR during the forecast period for 2024-2031. Gene therapy for cardiovascular disease shows promising potential but is primarily in the experimental and clinical t...

View Sample PDF

Microbiome_Manufacturing_Market.JPG

Microbiome Manufacturing Market Size, Share & Trends Analysis Report By Type of Product Manufactured (API and FDF), Type of Formulation (Solid, Liquid and Others), Type of Primary Packaging Used (Blister Packs, Glass / Plastic Bottles, Pouches / Sachets and Vials), Scale of Operation (Clinical and Commercial), Company Size (Small, Mid-sized, and Large and Very Large), By Region, And By Segment Forecasts, 2024-2031.

Microbiome Manufacturing Market Size is valued at USD 27.3 Mn in 2023 and is predicted to reach USD 84.8 Mn by the year 2031 at a 15.4% CAGR during the forecast period for 2024-2031. Microbiome manufacture integrates sophisticated biotechnological...

View Sample PDF

Liposomal_and_Lipid_Nanoparticle_Drug_Delivery_Systems_Market.JPG

Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Liposomes Drugs, Lipid Nanoparticle Drugs) By Application (Hospital, Retail Pharmacy, Other), By Region, And By Segment Forecasts, 2024-2031.

Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size is valued at USD 5.4 Bn in 2023 and is predicted to reach USD 10.8 Bn by the year 2031 at a 9.3% CAGR during the forecast period for 2024-2031 Both liposomal and lipid nanoparticle...

View Sample PDF

Levonorgestrel_API_Market.JPG

Levonorgestrel API Market Size, Share & Trends Analysis Report, By Type (Short-Acting Contraceptive API and Long-Acting Contraceptive API), By Application (Levonorgestrel Tablet, Mixture Products, and, Hormone-releasing IUD), By Region, Forecasts, 2024-2031

Levonorgestrel API Market Size was valued at USD 52.01 Mn in 2023 and is predicted to reach USD 71.37 Mn by 2031 at a 4.13% CAGR during the forecast period for 2024-2031. Levonorgestrel is a medicine that is mostly prescribed for the purpose of pr...

View Sample PDF

Minichromosomal_Technology_in_Agriculture_Market.JPG

Minichromosomal Technology in Agriculture Market Size, Share & Trends Analysis Report, By Trait Incorporated (Drought Tolerance, Improved Nitrogen Use, Herbicide Tolerance, Pest Resistance, Others), By Crop Type (Arabidopsis, Maize, Others), By End-user (Agriculture & Biotechnology Companies, Academic & Research Institutes, Others), By Region, Forecasts, 2024-2031

Minichromosomal Technology in Agriculture Market Size was valued at USD 324.7 Mn in 2023 and is predicted to reach USD 526.6 Mn by 2031 at a 6.40% CAGR during the forecast period for 2024-2031. Minichromosomal technology in agricultural genetic en...

View Sample PDF

Hyaluronic_Acid_API_Market.JPG

Hyaluronic Acid API Market Size, Share & Trends Analysis Report By Type (Animal Tissue, Microbial Fermentation), By Application (Cosmetics, Medical, Food), By Region, And By Segment Forecasts, 2024-2031.

Hyaluronic Acid API Market Size is valued at USD 501.85 Mn in 2023 and is predicted to reach USD 1,392.64 Mn by the year 2031 at a 13.77% CAGR during the forecast period for 2024-2031. Hyaluronic acid, when used as an active pharmaceutical ingredi...

View Sample PDF

Adrenocortical_Hormones_API_Market.JPG

Adrenocortical Hormones API Market Size, Share & Trends Analysis Report By Type (Dexamethasone Series, Betamethasone Series, Hydrocortisone Series & Others), By Application (Injectable Drugs, Oral Drugs, For External Use Drugs, Inhalation Drugs), By Region, And By Segment Forecasts, 2024-2031.

Adrenocortical Hormones API Market Size is valued at USD 2.24 Bn in 2023 and is predicted to reach USD 3.55 Bn by the year 2031 at a 6.04% CAGR during the forecast period for 2024-2031. Adrenocortical hormones, also referred to as corticosteroids ...

View Sample PDF

Categories